Mettler-Toledo Director Receives Equity Award Valued at ~$325k
METTLER TOLEDO INTERNATIONAL INC/
Subscribe to track MTD
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Mettler-Toledo Director Receives Equity Award
Company: METTLER TOLEDO INTERNATIONAL INC/ (MTD) Form: 4 | Filed: 2025-11-13 Significance: Low
Insider: Doat-Le Bigot Domitille Title: null | Relationship: Director
Transaction: • Type: Grant (Stock & Options) • Shares: 63 (Common Stock), 162 (Options) • Price: $0.00 • Value: ~$325,139 • Owned After: 295 shares
Key Insight: A routine equity grant to a director as part of standard compensation. The transaction value and share count are negligible compared to the company's large market capitalization.
Market Context: This award is a standard board compensation practice for a large-cap company and does not signal a shift in insider sentiment.
Comprehensive Analysis
SEC Filing Analysis: METTLER TOLEDO INTERNATIONAL INC/ (MTD)
Executive Summary
- Trading Significance: Low
- Key Takeaway: A Director received a routine, non-cash equity award as part of their compensation package, consisting of common stock and stock options.
- Market Impact: The transaction is negligible in size relative to Mettler-Toledo's market capitalization and is expected to have no impact on the stock.
Company Information
| Field | Value |
|---|---|
| Company | METTLER TOLEDO INTERNATIONAL INC/ |
| Ticker Symbol | MTD |
| CIK | 0001037646 |
| Industry | Laboratory Analytical Instruments |
Insider Information
| Field | Value |
|---|---|
| Name | Doat-Le Bigot Domitille |
| CIK | 0001800804 |
| Title/Position | null |
| Relationship | Director |
Transaction Details
This filing reports two 'A' code (Award) transactions: a grant of common stock and a grant of stock options.
Transaction 1: Common Stock Grant
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2025-11-11 |
| Transaction Code | A (Award) |
| Security Type | Common Stock, par value $0.01 per share |
| Shares Involved | 63 |
| Price Per Share | $0.00 |
| Total Value | $91,039 |
| Shares Owned After | 295 |
| Ownership Type | Direct |
Transaction 2: Stock Option Grant
| Field | Value |
|---|---|
| Security Type | Stock Option (right to buy) |
| Shares Involved | 162 |
| Exercise Price | $1445.06 |
| Expiration Date | 2035-11-11 |
Financial Impact Assessment
Transaction Materiality
The analysis combines the impact of both the stock and option grants.
| Metric | Value |
|---|---|
| Total Award Value | ~$325,139 (63 shares @ $1445.06 + 162 options underlying value) |
| % of Market Cap | 0.0011% |
| Total Shares Transacted | 225 (63 stock + 162 underlying options) |
| % of Shares Outstanding | 0.0011% |
| Post-Transaction Ownership | 295 shares (0.0014% of outstanding) |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: The total award value of approximately $325k is immaterial for a company with a market capitalization of $29.27 billion.
- Ownership Concentration: The director's direct ownership remains extremely low at 0.0014% of total shares outstanding, indicating no significant concentration of control.
- Dilution Impact: The 225 shares (granted and underlying options) represent a negligible 0.0011% of shares outstanding, posing no meaningful dilution risk to existing shareholders.
- Transaction Significance: Based on the transaction's value being less than 0.1% of market cap and shares involved being less than 0.1% of shares outstanding, the significance is low. This is a standard compensatory grant.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: This is a non-market transaction related to director compensation. It does not reflect a discretionary investment decision by the insider and carries no new information about the company's prospects.
Volume & Sentiment
- Expected Volume Impact: None. The transaction is an award, not an open-market trade, and will not affect trading volume.
- Sentiment Indicator: Neutral. Compensatory grants are routine and do not signal bullish or bearish sentiment.
Additional Context
Transaction Notes
- Vesting Schedule: The 162 stock options vest in two equal annual installments, beginning one year from the grant date.
- Valuation Note: The value of the common stock grant ($91,039) was estimated using the exercise price of the concurrently granted options ($1445.06) as a proxy for the market price on the date of grant.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
